Edition:
United Kingdom

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

8.20CAD
19 Jul 2019
Change (% chg)

$-0.06 (-0.73%)
Prev Close
$8.26
Open
$8.27
Day's High
$8.30
Day's Low
$8.20
Volume
18,701
Avg. Vol
45,966
52-wk High
$10.47
52-wk Low
$6.61

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 2.13
Market Cap(Mil.): $689.24
Shares Outstanding(Mil.): 83.54
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -1.70 -- --
ROI: -60.83 8.94 14.49
ROE: -70.80 10.07 15.79

Earnings vs. Estimates